Results 71 to 80 of about 6,549 (182)

Prospective Registry and Meta‐Analysis of Particle Therapy for Hepatocellular Carcinoma: Clinical Outcomes and Real‐World Impact

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background and Aims This study aimed to evaluate the clinical efficacy of particle therapy for hepatocellular carcinoma (HCC) by integrating a prospective registry and a systematic meta‐analysis. Our findings also reflect the real‐world impact of this evidence, which contributed to the national health insurance approval of particle therapy for
Masashi Mizumoto, Kei Shibuya, Kazuki Terashima, Hiromitsu Iwata, Takashi Saito, Shingo Toyama, Takashi Ogino, Masao Murakami, Tatsuya Ohno, Yoshitaka Sato, Tetsuo Akimoto, Hiroyuki Katoh, Masaru Wakatsuki, Takahiro Waki, Norio Katoh, Fuki Koizumi, Masayuki Araya, Tsuyoshi Onoe, Masaru Takagi, Tomoaki Okimoto, Hiroyuki Ogino, Haruko Numajiri, Yoshiyuki Shioyama, Takayuki Hashimoto, Hisateru Ohba, Shoji Kubo, Kiyoshi Hasegawa, Kazushi Maruo, Hidefumi Aoyama, Hideyuki Sakurai   +29 more
wiley   +1 more source

A Clinical Trial of The Evaluation of Environmental Exposure in Yttrium 90 Radioembolization

Sakarya Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 2018
Aim: The aim of this study is to measure the dose rate of twodifferent forms of Y-90 microsphere used for radioembolization and to evaluatethe results according to radiation safety regularities.
Handan Tanyildizi, İffet Çavdar, Mustafa Demir   +2 more
doaj   +1 more source

Five Advances in the Last 50 Years: Liver Malignancies

World Journal of Surgery, Volume 50, Issue 8, Page 2116-2120, August 2026.
Alex B. Blair, Timothy M. Pawlik
wiley   +1 more source

Liver Transplantation After Combination Therapy Based on Immune Checkpoint Inhibitors: A Multicenter Retrospective Study of Safety and Efficacy

Organ Medicine, Volume 3, Issue 1, Page 12-19, March 2026.
This multicenter retrospective study assessed preoperative immune checkpoint inhibitor (ICI) therapy in 17 hepatocellular carcinoma patients undergoing liver transplantation. All received at least one cycle of ICI‐based combination therapy before transplant and achieved a 76.5% objective response rate.
Huanquan Chen, Tianxing Dai, Jie Gao, Chuanjiang Li, Huanwei Chen, Feiwen Deng, Nan Ma, Guoying Wang   +7 more
wiley   +1 more source

Building a high-performing yttrium-90 radioembolization practice: from evidence to experience

CVIR Oncology
Yttrium-90 (90Y) radioembolization has evolved into a guideline-endorsed liver-directed therapy with curative, bridging, downstaging, and palliative applications in selected patients with hepatocellular carcinoma (HCC) and liver-dominant malignancies ...
Christopher Malone, Christopher Friend, Brittany Schmitt, Gary Siskin, Isabel Newton   +4 more
doaj   +1 more source

Radioembolization [PDF]

, 2020
Caren van Roekel, Arthur J. A. T. Braat, Maarten L. J. Smits, Rutger C. G. Bruijnen, Bart de Keizer, Marnix G. E. H. Lam   +5 more
openaire   +2 more sources

Laparoscopic right hepatectomy for hepatocellular carcinoma after sequential yttrium-90 liver radioembolization and liver venous deprivation (with video)

Journal of Minimally Invasive Surgery
Laparoscopic right hepatectomy has gained acceptance for major oncologic hepatectomies. Preoperative sequential strategies for induced tumor downsizing and contralateral liver hypertrophy ensure the safety of these major hepatectomies, especially in ...
Pierre De Mathelin, Pietro Addeo
doaj   +1 more source

Radiation Segmentectomy for Hepatocellular Carcinoma

Current Oncology
The application of trans-arterial radioembolization (TARE) with Yttrium-90, historically a palliative treatment option for patients with advanced hepatocellular carcinoma (HCC), is evolving.
Muhamad Serhal, Farnaz Dadrass, Edward Kim, Robert J. Lewandowski   +3 more
doaj   +1 more source

Radioembolization for the treatment of hepatocellular carcinoma [PDF]

Clinical and Molecular Hepatology, 2017
Transarterial radioembolization (TARE) with yttrium 90 (90Y), an intra-arterial procedure performed by interventional radiologists, has begun being utilized in managing hepatocellular carcinoma (HCC) in Korea. There are two available TARE products: glass and resin microspheres with different physical characteristics.
openaire   +3 more sources

TACE Versus TARE in the Treatment of Liver-Metastatic Breast Cancer: A Systematic Review

Tomography
Background/Objectives: Liver metastases are common among patients with breast cancer and have a poor prognosis if left untreated. The aim of this systematic review is to evaluate and compare chemoembolization (TACE) versus radioembolization (TARE ...
Charalampos Lalenis, Alessandro Posa, Valentina Lancellotta, Marcello Lippi, Fabio Marazzi, Pierluigi Barbieri, Patrizia Cornacchione, Matthias Joachim Fischer, Luca Tagliaferri, Roberto Iezzi   +9 more
doaj   +1 more source